Axiolume / Journal

    Source-backed research, explained clearly.

    The Journal contains source-backed explainers, research updates, and evidence commentary, with limitations and disclosures kept visible.

    Journal

    SS-31 vs. MOTS-c: Two Mitochondrial Peptides, Different Strategies

    Mitochondrial peptides capture attention in research discussions.

    Read article
    Journal

    Semaglutide for MASH: What ESSENCE Trial Biopsy Results and FDA Accelerated Approval Show

    Source-Backed Journal Explainer This is the first Axiolume Journal article on semaglutide MASH evidence.

    Read article